Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b |
| |
Authors: | P Bramanti E Sessa C Rifici G D'Aleo D Floridia P Di Bella F Lublin |
| |
Affiliation: | Centro per lo Studio ed il Trattamento dei Neurolesi Lungodegenti, Cattedra di Neurofisiopatologia, University of Messina, Italy. |
| |
Abstract: | Spasticity is a disabling symptom of MS that is enhanced during interferon beta-lb (IFNbeta-1b) treatment. Nineteen patients with primary progressive MS were treated with IFNbeta-1b; an additional 19 patients did not receive this treatment. Thirteen of the 19 patients treated with IFNbeta-1b had increased spasticity requiring increased antispasticity drug administration. This observation suggests that further studies are needed before interferons can be so widely used in primary progressive MS patients. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |